Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Alcovit Zeolite Clinoptilolite

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07332429Not ApplicableNot Yet Recruiting

Efficacy and Safety of Alcovit in Reducing Blood Alcohol Concentration

NCT03998397Not ApplicableCompleted

Self-estimates and Objective Blood Alcohol Concentration in Emergency Department

Showing all 2 trials

Research Network

Common Treatments

  • Alcovit Zeolite Clinoptilolite1
  • Blood Alcohol Concentration Withdrawal1

Active Sponsors

  • Centre Hospitalier Universitaire, Amiens1
  • Hospital Santa Casa de Misericordia de Campos1
  • Galzu Institute of Research, Teaching, Science and Applied Technology1

Top Investigators

Related Conditions

  • Alcohol Use Disorder1
  • Alcohol Drinking1
  • Hangover1

Activity Timeline